Litcius/Paper detail

Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies

Mohammad Asgari, Maryam Mohammadi‐Khanaposhtani, Zeinab Sharafi, Mohammad Ali Faramarzi, Hossein Rastegar, Ensieh Nasli‐Esfahani, Fatemeh Bandarian, Parviz Ranjbar Rashidi, Rahmatollah Rahimi, Mahmood Biglar, Mohammad Mahdavi, Bagher Larijani

2020Molecular Diversity38 citationsDOI

Topics & Concepts

AcarboseChemistryDocking (animal)IC50Stereochemistry1,2,3-TriazoleClick chemistryImidazole1,2,4-TriazoleIn vitroTriazolePyrimidineYeastCombinatorial chemistryEnzymeMedicinal chemistryOrganic chemistryBiochemistryMedicineNursingClick Chemistry and ApplicationsHIV/AIDS drug development and treatmentSynthesis and biological activity
Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies | Litcius